WiSB Women’s Hour - Giving Birth to a Biotech with Caroline Barelle

Join the WiSB Women’s Hour – a regular opportunity to learn, share and support women and underrepresented genders in synthetic biology!

About this event
Giving birth to a Biotech - where is the pain relief!

This session will cover the process of a Biotech journey including:

• Conception - differing from competitors
• Delivery - getting a biotech off the ground
• Growth - securing investment for expansion

Joined by Dr Caroline Barelle who will be providing excerpts from experience, covering what to expect at every step of the biotech journey.

The presentation will be followed by a Q/A and an opportunity to break out into further discussions.

Presenter: Dr Caroline Barelle, CEO, Elasmogen

Caroline is CEO and founder of Elasmogen, a company that discovers and develops soloMER biologics for the treatment of inflammatory diseases and cancer. Before establishing Elasmogen, she successfully led teams at Wyeth and subsequently Pfizer in Global Bio-therapeutic Technologies progressing early platform technologies to late-stage clinical development. Prior to this, she was Alliance and Programs Manager at Haptogen Ltd and a key part of the acquisition team that successfully exited the business to Wyeth Inc.

Caroline has been awarded a prestigious Royal Society of Edinburgh Enterprise Fellowship, is a doctoral graduate from the University of Aberdeen in Biochemistry and an MBA (distinction) from Robert Gordon’s University, Business School. Caroline is a member of the Enterprise Skills and Strategy Board, a member of the Opportunity North East Life Sciences Board, a Senior Associate for the Entrepreneurial Business School, Edinburgh and Entrepreneur in Residence for Queen’s University Belfast.

Organisers

WiSB - Connecting and supporting women and underrepresented genders across the world of engineered biology.

Supported by BuiltWithBiology, Potter Clarkson and the Industrial Biotechnology Innovation Centre.

This event is free to attend